EXERCISE PROGRAM FOR THE PREVENTION OF OSTEOPOROTIC FRACTURE
With
Belinda Beck,
Professor of Exercise Science,
Griffith University &
Owner and Director, The Bone Clinic &
Member of Medical and Scientific Advisory Committee
Healthy Bones Australia (formerly Osteoporosis Australia)
RESEARCHER PROFILE
Filmed in Southport, Queensland, Australia | May 2025
Dr Beck is an international leader in the effects of mechanical loading on bone health. Dr Beck graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (California, USA.) She is a Professor of Exercise Science at Griffith University Gold Coast campus, where she has led the Bone Densitometry Research Laboratory since 2004.
Dr Beck has been awarded $7.6M in research grant funding to work on both animal and human models, from basic to clinical research. She has extensive experience leading clinical trials and the development of methodologies in musculoskeletal measurement. Her particular focuses have been exercise interventions across the lifespan for bone health, and bone stress injuries in athlete and military populations. In recent years she developed the first effective exercise program for the prevention of osteoporotic fracture.
The impact and significance of her work are reflected in 108 peer-reviewed journal articles (80% Q1 journals, 83.3% in top 25% journals by CiteScore), 7 chapters and 16 consumer publications in her field. Over 35% of her publications are in the top 10% most viewed publications worldwide (SciVal).
She has supervised 11 PhD, 5 Masters and 13 Honours students to completion and is currently supervising 2 PhD students, 1 Masters and 1 Honours student, along with three research associates (fellows and assistants). She has delivered 40 invited presentations worldwide (e.g., London, Italy, France, Germany, and the USA) and 57 nationally. She is a Board member of the International Osteoporosis Foundation Capture the Fracture programme, Sports Medicine Australia, the Australian and New Zealand Bone and Mineral Society and a Fellow of the American Society of Bone and Mineral Research, the American College of Sports Medicine, Sports Medicine Australia and Exercise Sports Science Australia.
Dr Beck’s research impact stems from the results of successful and innovative clinical trials and methodological studies that have changed practice in the fields of osteoporosis and military medicine and research practice. The implementation of her research outcomes in the real world seek to make genuine and significant differences to the quality and productivity of people.
Source: Adapted from supplied copy
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
Funding the best brains to beat brain cancer
The Charlie Teo Foundation is dedicated to funding and advancing research into brain cancer, with a particular focus on developing more effective treatments and finding a cure for this devastating disease.
Since its inception, the foundation has committed nearly $15 million to brain cancer research, funding notable projects in Australia and the United States. These projects explore innovative approaches to understand and treat brain cancer more effectively, with a focus on translating findings from animal studies to human applications. Charlie’s dedication to finding solutions for this devastating disease remains unwavering as he travels frequently to collaborate with global researchers.
